Hussaarts L, Mühlebach S, Shah VP, McNeil S, Borchard G, Flühmann B, et al. Equivalence of complex drug products: advances in and challenges for current regulatory frameworks. Ann N Y Acad Sci. 2017;1407(1):39–49.

Article  PubMed  Google Scholar 

Shah VP, Maibach HI, Jenner J. Topical drug bioavailability, bioequivalence, and penetration. Berlin: Springer; 2015.

Klein K, Borchard G, Shah VP, Flühmann B, McNeil SE, de Vlieger JSB. A pragmatic regulatory approach for complex generics through the U.S. FDA 505(j) or 505(b)(2) approval pathways. Ann N Y Acad Sci. 2021;1502(1):5–13.

Article  PubMed  PubMed Central  Google Scholar 

Lunawat S, Bhat K. Complex generic products: insight of current regulatory frameworks in US, EU and Canada and the need of harmonisation. Ther Innov Regul Sci. 2020;54(5):991–1000.

Article  PubMed  Google Scholar 

Holmgaard R, Benfeldt E, Bangsgaard N, Sorensen JA, Brosen K, Nielsen F, et al. Probe depth matters in dermal microdialysis sampling of benzoic acid after topical application: an ex vivo study in human skin. Skin Pharmacol Physiol. 2012;25(1):9–16.

Article  CAS  PubMed  Google Scholar 

Gaiser A, Lunter D. Investigation of the suitability of confocal Raman spectroscopy for the demonstration of bioequivalence of topical products. Int J Pharm. 2025;671:125214.

Article  CAS  PubMed  Google Scholar 

Cordery SF, Pensado A, Chiu WS, Shehab MZ, Bunge AL, Delgado-Charro MB, et al. Topical bioavailability of diclofenac from locally-acting, dermatological formulations. Int J Pharm. 2017;529(1–2):55–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kasuga M, Kuwana K, Kuribayashi R. Regulation for the bioequivalence evaluation of generic topical dermatological drug products in Japan. Eur J Drug Metab Pharmacokinet. 2025;50(4):353–61.

Article  CAS  PubMed  Google Scholar 

Stoughton RB. Are generic formulations equivalent to trade name topical glucocorticoids? Arch Dermatol. 1987;123(10):1312–4.

Article  CAS  PubMed  Google Scholar 

Cornell RC, Stoughton RB. Correlation of the vasoconstriction assay and clinical activity in psoriasis. Arch Dermatol. 1985;121(1):63–7.

Article  CAS  PubMed  Google Scholar 

EMA. Guideline on quality and equivalence of locally applied, locally acting cutaneous products European Medicines Agency; 2024.

US-FDA. Draft guidance on topical dermatologic corticosteroids: In Vivo bioequivalence. U.S. Food and Drug Administration; 2023.

US-FDA. Guidance on residual drug in transdermal and related drug delivery systems. U.S. Food and Drug Administration; 2011.

Hadgraft J, Lane ME. Drug crystallization—implications for topical and transdermal delivery. Expert Opin Drug Deliv. 2016;13(6):817–30.

Article  CAS  PubMed  Google Scholar 

Lazar M, Zhang AD, Vashi NA. Topical treatments in atopic dermatitis: an expansive review. J Clin Med. 2024;13(8).

Alves C, Penedones A, Mendes D, Batel Marques F. Topical Janus kinase inhibitors in atopic dermatitis: a safety network meta-analysis. Int J Clin Pharm. 2023;45(4):830–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Montero-Vilchez T, Segura-Fernández-Nogueras MV, Pérez-Rodríguez I, Soler-Gongora M, Martinez-Lopez A, Fernández-González A et al. Skin barrier function in psoriasis and atopic dermatitis: transepidermal water loss and temperature as useful tools to assess disease severity. J Clin Med. 2021;10(2).

Feingold KR. Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J Lipid Res. 2007;48(12):2531–46.

Article  CAS  PubMed  Google Scholar 

Jin X, Imran M, Mohammed Y. Topical semisolid products-understanding the impact of metamorphosis on skin penetration and physicochemical properties. Pharmaceutics. 2022;14(11).

OECD. Test No. 428: Skin Absorption: In Vitro Method. 2004.

OECD. Test No. 427: Skin Absorption: In Vivo Method. 2004.

Agency EM. Guideline on quality and equivalence of locally applied, locally acting cutaneous products. EMA; 2024.

Lourenço D, Miranda M, Sousa JJ, Vitorino C. Therapeutic-driven framework for bioequivalence assessment of complex topical generic drug products. Int J Pharm. 2024;661:124398.

Article  PubMed  Google Scholar 

US-FDA. Draft Guidance for Industry: Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs. 2022.

Baumann KY, Church MK, Clough GF, Quist SR, Schmelz M, Skov PS, et al. Skin microdialysis: methods, applications and future opportunities-an EAACI position paper. Clin Transl Allergy. 2019;9:24.

Article  Google Scholar 

Ault JM, Riley CM, Meltzer NM, Lunte CE. Dermal microdialysis sampling in vivo. Pharm Res. 1994;11(11):1631–9.

Article  CAS  PubMed  Google Scholar 

Darvin ME. Optical methods for non-invasive determination of skin penetration: current trends, advances, possibilities, prospects, and translation into in vivo human studies. Pharmaceutics. 2023;15(9).

Pena AM, Chen X, Pence IJ, Bornschlögl T, Jeong S, Grégoire S, et al. Imaging and quantifying drug delivery in skin—part 2: fluorescence andvibrational spectroscopic imaging methods. Adv Drug Deliv Rev. 2020;153:147–68.

Article  CAS  PubMed  PubMed Central  Google Scholar